3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
cyclopia sequence
8
Lung Neoplasms
3
Pain
2
Neoplasms, Plasma Cell
2
Multiple Myeloma
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Sleepiness
1
Peripheral Nervous System Diseases
1
Parasomnias
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Hypesthesia
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Fatigue
1
Exanthema
1
Esophageal Neoplasms
1
Depression
1
Colorectal Neoplasms
1
Anxiety Disorders
1
Anorexia
1
Acute Pain
1
Interventions
Temozolomide
88
Bevacizumab
49
Radiotherapy
36
Irinotecan
22
Magnetic Resonance Spectroscopy
21
Surgical Procedures, Operative
17
Carboplatin
17
Carmustine
15
Radiation
13
Nivolumab
11
IL13-PE38
8
Erlotinib Hydrochloride
8
Thalidomide
7
Radiotherapy, Intensity-Modulated
7
Lomustine
7
Imatinib Mesylate
7
Everolimus
7
Aminolevulinic Acid
7
sargramostim
6
Topotecan
6
O(6)-benzylguanine
6
Cyclophosphamide
6
Chemotherapy, Adjuvant
6
vandetanib
5
temsirolimus
5
fluorodopa F 18
5
Vincristine
5
Surveys and Questionnaires
5
Radiosurgery
5
Flucytosine
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Glioma
×
Minocycline
×
Clear all
NCT01580969
2019-08-16
RAMBO
University of Utah
Phase 1/2
Completed
22 enrolled
18 charts